Prostate Neoplasms Approved for Marketing Phase Trials for Abiraterone (DB05812)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Approved for MarketingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01217697Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer